国产91长腿美女在线观看._国产私人影院在线播放_激情销魂乳妇奶水小说_中文日韩精品欧美一区_黄色软件app大全免费下载_国产狂喷水潮免费网站WWW_亚洲欧美高清精品a∨_國產一區二區三區亂碼_蕉综合色狠狠_免费人成网站在线观看高清
<dl id="i68as"><xmp id="i68as"></xmp></dl>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.06.19
會(huì)計(jì)師事務(wù)所選聘制度（2010年6月）
2010.06.19
關(guān)于高級(jí)管理人員聘任和辭職的公告
2010.06.19
中國(guó)建銀投資證券有限責(zé)任公司關(guān)于公司2010年度日常關(guān)聯(lián)交易的核查意見(jiàn)
2010.06.19
關(guān)于召開(kāi)2010年第二次臨時(shí)股東大會(huì)的通知
2010.06.19
第一屆監(jiān)事會(huì)第八次會(huì)議決議公告
2010.06.19
累積投票制實(shí)施細(xì)則（2010年6月）
2010.06.19
年報(bào)信息披露重大差錯(cuò)責(zé)任追究制度（2010年6月）
2010.06.19
董事會(huì)提名委員會(huì)關(guān)于聘任管理人員的審核意見(jiàn)
2010.06.19
關(guān)于2010年度預(yù)計(jì)日常經(jīng)營(yíng)性關(guān)聯(lián)交易事項(xiàng)的公告
2010.06.19
內(nèi)部問(wèn)責(zé)制度（2010年6月）
第一頁(yè)
上一頁(yè)
150
151
152
153
154
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
